EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. The company operates in two divisions: High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS). The HIFU division develops, manufactures, and markets devices for the minimally invasive destruction of various types of localized tumors using HIFU technology.
Read More…
Industry, Sector and Symbol
Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Phone33-04-72-15-31-50
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$46.17 million
Profitability
Miscellaneous
Employees215
Next Earnings Date11/13/2019 (Estimated)
OptionableOptionable
Edap Tms (NASDAQ:EDAP) Frequently Asked Questions
What is Edap Tms' stock symbol?
Edap Tms trades on the NASDAQ under the ticker symbol "EDAP."
How were Edap Tms' earnings last quarter?
Edap Tms SA (NASDAQ:EDAP) posted its quarterly earnings results on Wednesday, August, 28th. The medical equipment provider reported $0.05 EPS for the quarter, topping the Zacks' consensus estimate of $0.01 by $0.04. The medical equipment provider earned $14.04 million during the quarter, compared to the consensus estimate of $11.92 million. Edap Tms had a return on equity of 23.31% and a net margin of 4.57%. View Edap Tms' Earnings History.
When is Edap Tms' next earnings date?
What price target have analysts set for EDAP?
1 brokers have issued 12 month price objectives for Edap Tms' shares. Their forecasts range from $7.00 to $7.00. On average, they expect Edap Tms' share price to reach $7.00 in the next twelve months. This suggests a possible upside of 73.3% from the stock's current price. View Analyst Price Targets for Edap Tms.
What is the consensus analysts' recommendation for Edap Tms?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Edap Tms in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Edap Tms.
Has Edap Tms been receiving favorable news coverage?
Media headlines about EDAP stock have been trending somewhat positive on Monday, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Edap Tms earned a media sentiment score of 0.9 on InfoTrie's scale. They also gave press coverage about the medical equipment provider a news buzz of 1.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for Edap Tms.
Are investors shorting Edap Tms?
Edap Tms saw a drop in short interest during the month of August. As of August 31st, there was short interest totalling 80,300 shares, a drop of 22.0% from the July 31st total of 102,900 shares. Based on an average daily volume of 148,800 shares, the short-interest ratio is currently 0.5 days. Approximately 0.3% of the shares of the stock are sold short. View Edap Tms' Current Options Chain.
Who are some of Edap Tms' key competitors?
Some companies that are related to Edap Tms include Cutera (CUTR), BioLife Solutions (BLFS), Viewray (VRAY), Zynex (ZYXI), Stereotaxis (STXS), Semler Scientific (SMLR), Rockwell Medical (RMTI), BioSig Technologies (BSGM), Fonar (FONR), Second Sight Medical Products (EYES), electroCore (ECOR), Fc Global Realty (FCRE), Soleno Therapeutics (SLNO), Helius Medical Technologies (HSDT) and IRIDEX (IRIX).
What other stocks do shareholders of Edap Tms own?
Who are Edap Tms' key executives?
Edap Tms' management team includes the folowing people:
- Mr. Marc Oczachowski, CEO & Exec. Director (Age 49)
- Mr. Franois Dietsch, Chief Financial Officer (Age 43)
- Ms. Blandine Confort, Investor Relations Officer and Sec.
Who are Edap Tms' major shareholders?
Edap Tms' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Fosun International Ltd (1.37%), Morgan Stanley (0.92%), Acadian Asset Management LLC (0.78%), Susquehanna International Group LLP (0.71%) and JPMorgan Chase & Co. (0.34%).
Which major investors are buying Edap Tms stock?
EDAP stock was purchased by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC, Morgan Stanley, Susquehanna International Group LLP, JPMorgan Chase & Co. and Fosun International Ltd.
How do I buy shares of Edap Tms?
Shares of EDAP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Edap Tms' stock price today?
One share of EDAP stock can currently be purchased for approximately $4.04.
How big of a company is Edap Tms?
Edap Tms has a market capitalization of $117.15 million and generates $46.17 million in revenue each year. The medical equipment provider earns $-400,000.00 in net income (profit) each year or $0.02 on an earnings per share basis. Edap Tms employs 215 workers across the globe.View Additional Information About Edap Tms.
What is Edap Tms' official website?
How can I contact Edap Tms?
Edap Tms' mailing address is Parc d'Activites la Poudrette-Lamartine 4/6 rue du Dauphine, Vaulx-en-Velin I0, 69120. The medical equipment provider can be reached via phone at 33-04-72-15-31-50 or via email at [email protected]
MarketBeat Community Rating for Edap Tms (NASDAQ EDAP)
MarketBeat's community ratings are surveys of what our community members think about Edap Tms and other stocks. Vote "Outperform" if you believe EDAP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EDAP will underperform the S&P 500 over the long term. You may vote once every thirty days.
